Pharmacokinetics and Safety of Intravenous Candidate Biosimilar CT-P47 and Reference Tocilizumab: A Randomized, Double-Blind, Phase 1 Study.
JOURNAL OF CLINICAL PHARMACOLOGY(2024)
关键词
biosimilar,CT-P47,immunogenicity,pharmacokinetics,safety,tocilizumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要